Bladder Cancer in Tanzania: Awareness Gaps and the Need for Early Detection

 

Bladder Cancer in Tanzania: Awareness Gaps and the Need for Early Detection

Feliciana Mshanga Memorial Cancer Foundation in Collaboration with World Bladder Cancer Patient Coalition

Introduction: The Cancer We Are Not Talking About Enough

Bladder cancer remains one of the most overlooked cancers in Tanzania. While national attention has rightly focused on cervical and breast cancer, bladder cancer continues to grow quietly—often detected too late, and too deadly as a result.

According to the Global Cancer Observatory (GLOBOCAN) 2022, Tanzania records approximately 44,900 new cancer cases annually, with bladder cancer contributing a smaller yet significant portion. However, experts caution that the true burden is likely higher due to under diagnosis and limited reporting systems.

This is not just a medical issue, it is an awareness crisis.

Burden of Bladder Cancer in Tanzania

According to the Global Cancer Observatory (GLOBOCAN) 2022, recent data highlights a worrying trend:  

·         ~1,142 new cases annually

·         ~613 deaths annually

·         Over 50% mortality rate among diagnosed cases

This shows a high mortality burden, where more than half of diagnosed patients die, largely due to late diagnosis and limited access to treatment.

Local hospital and registry data from the Ocean Road Cancer Institute (ORCI) and regional cancer registries suggest that bladder cancer accounts for about 1–3% of all cancers in Tanzania, with higher concentration in men and in schistosomiasis-endemic regions particularly around Lake Victoria.  

According to GLOBOCAN 2022, globally around 2,466 people are living with bladder cancer within five years of diagnosis. However in Tanzania, according to Tanzania Ministry of Health.Population-Based Cancer Registry Report, 2019–2023, most cases are found in adults between 40–60 years old, especially in areas around Lake Victoria, where schistosomiasis (a water-borne infection) is common.

Furthermore, studies at Bugando Medical Centre found that more than half of bladder cancers (57%) were squamous cell carcinoma, a type strongly linked to schistosomiasis.

 

Understanding Bladder Cancer

Bladder cancer starts in the lining of the bladder. The most common early warning sign is blood in urine (hematuria) often painless and frequently ignored.

Other symptoms include:

• Frequent urination
• Pain during urination
• Lower abdominal pain

Unfortunately, many people mistake these signs for common infections, leading to dangerous delays in seeking care.

 

A Unique Pattern in Tanzania: Two Different Diseases in One

Bladder cancer in Tanzania presents in a way that is very different from high-income countries. It follows a dual pattern, driven by both infection and lifestyle factors.

1. Squamous Cell Carcinoma (SCC) – Most Common in Endemic Areas

• Accounts for ~50–75% of cases in schistosomiasis-endemic regions of Tanzania
• Strongly linked to Schistosomiasis (bilharzia)
• Most common in: Lake Zone (Mwanza, Mara, Shinyanga, Kagera)

Chronic infection from contaminated water causes long-term bladder irritation, eventually leading to cancer.

This type of bladder cancer is largely preventable through clean water access, schistosomiasis control programs, public health education.

 

2. Transitional Cell Carcinoma (TCC / Urothelial Carcinoma) – Urban Type

• Represents about 25–40% of bladder cancer cases in Tanzania
• Increasing in urban centers such as: Dar es Salaam, Arusha and Kilimanjaro

Risk factors for this type of bladder cancer are smoking, industrial chemical exposure and aging population.

This type of bladder cancer is more similar to global bladder cancer patterns and it has better outcomes if detected early.

Globally, this is the most common type (>90%), but in Tanzania it ranks second due to the high burden of infection-related cancers.

3. Adenocarcinoma (Rare)

• Less than 5% of cases
• Associated with chronic inflammation or rare conditions

 

Regional Pattern in Tanzania

Region	Most Common Type	Main Cause
Lake Zone (Mwanza, Mara, Kagera)	Squamous Cell Carcinoma	Schistosomiasis
Urban areas (Dar es Salaam, Arusha and Kilimanjaro)	Transitional Cell Carcinoma	Smoking, chemicals
Rural irrigation zones	Mixed	Infection + environment

 

Why Are Patients Diagnosed So Late?

Late diagnosis is one of the biggest challenges in Tanzania.

Common reasons include:

• Ignoring blood in urine or treating it as infection. Blood in urine or frequent urination is often dismissed as “normal” or linked to other problems.  
• Low public awareness of cancer symptoms. Campaigns focus on cervical and breast cancer, leaving bladder cancer out of the conversation.
• Limited diagnostic services outside major cities. Tests like cystoscopy are mostly available in big cities like Dar es Salaam and Mwanza. Rural areas have little access.
• Weak referral systems from primary health facilities
• Stigma. Talking about urinary health is uncomfortable, so people delay seeking help.

As a result, many patients arrive at hospitals when the disease is already advanced—when treatment options are limited and survival chances are low.

Studies show that most patients present at advanced stages, reducing survival chances significantly.

 

Why Early Detection Saves Lives

Bladder cancer is highly treatable when detected early.

• Survival can exceed 70–90% when detected early (American Cancer Society)
• Late-stage disease often requires major surgery and has poor outcomes

This means that awareness alone can save lives.

 

Key Message for the Public

Blood in urine is not normal. It is a warning sign. Seek medical care immediately.

Even a single episode should not be ignored.

This single message, if widely understood, could transform outcomes across the country.

 

What Tanzania Must Do Now

To reduce deaths from bladder cancer, urgent action is needed:

1. Increase Awareness

• Nationwide education campaigns
• Focus on rural and high-risk regions especially lake zones.

2. Strengthen Prevention

·         Scale up schistosomiasis control programs

·         Improve access to safe water and sanitation

3. Health System Strengthening

• Expand diagnostic tools (cystoscopy, imaging)
• Train frontline health workers

4. Build Strong Referral Systems

•  Ensure early movement of patients from dispensaries to specialized care

5. Strengthen Cancer Registries

• Expand population-based cancer registries across the country
• Improve data collection, reporting, and digital systems
• Use data to identify high-risk regions and guide interventions 

6. Establish and Support Patient Support Groups

• Create bladder cancer and urology patient support groups at hospitals and community level
• Provide; psychosocial support, patient education, peer-to-peer encouragement
• Empower survivors to become advocates and awareness champions

7. Strengthen Partnerships

• Collaborate with Government (Ministry of Health), Hospitals (e.g., Ocean Road Cancer Institute, regional centers), NGOs and international partners
• Align bladder cancer efforts with broader national cancer control strategies

 

Conclusion: Closing the Awareness Gap

Bladder cancer in Tanzania is not one disease, it is two realities:

• A preventable, infection-driven cancer in rural communities
• A lifestyle-related cancer emerging in urban areas

With over 1,142 new cases and 613 deaths annually (GLOBOCAN 2022), the burden is clear and so is the opportunity.

This is not just a treatment challenge. It is an awareness and early detection gap. By investing in education, prevention, and early diagnosis, Tanzania can significantly reduce deaths from this silent but deadly cancer.

References

1. Rambau PF et al. (2013). Schistosomiasis and urinary bladder cancer in Northwestern Tanzania. Infectious Agents and Cancer.
2. Chalya PL et al. (2013). Urological cancers in Northwestern Tanzania: patterns and challenges. World Journal of Surgical Oncology.
3. World Health Organization (WHO). Schistosomiasis (Bilharzia) Fact Sheet.
4. Tanzania Ministry of Health. (2019–2023). National Cancer Registry Report.
5. Global Cancer Observatory (GLOBOCAN). (2022). Tanzania Cancer Fact Sheet.
6. International Agency for Research on Cancer (IARC). (2022). Global Cancer Data.
7. Yohana C et al. (2023). Trends of schistosomiasis-related bladder cancer in Tanzania’s lake zone. Infectious Agents and Cancer.
8. IARC BEED Study. (2023/2024). Bladder Cancer Early Detection in Africa.

 

Public Acknowledgement;

This article was prepared by the Feliciana Mshanga Memorial Cancer Foundation in collaboration with the World Bladder Cancer Patient Coalition (WBPC). 

Our shared commitment is to raise awareness, strengthen patient support, and promote early detection of bladder cancer in Tanzania and globally.